Structure and Properties | Early Cancer Treatments | Discovery | Treatment and Side Effects | Historical Significance
Treatment
Cisplatin was approved for use in the United States in 1978 by the Food and Drug Administration after years of studies and testing.
Cisplatin is used to treat primarily sarcoma cancers. It is believed to kill cancer cells by binding to them and interfering with the cell’s ability to repair itself. This eventually leads to the death of the cell.
Cisplatin is used through chemotherapy (the treatment of disease through the use of chemicals to kill or modify cells). Cisplatin falls into the Alkylating Agent group because it often adds an alkyl group to electronegative groups in cells.
Side Effects
-Fatigue
-Nausea
-Neurotoxicity
-Nephrotoxicity